Companies:
53,513
Total Market Cap:
174682514534409.71
GT Biopharma
NASDAQ: GTBP
Healthcare
Biotechnology
Global Rank
#42351
Country Rank
#5187
Market Cap
10.38 M
Price
0.23
Change (%)
8.80%
Volume
675,976
GT Biopharma's latest marketcap:
10.38 M
As of 09/04/2026, GT Biopharma's market capitalization has reached $10.38 M. According to our data, GT Biopharma is the 42351th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 10.38 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -11,380,000 |
| Shares Out | 45.11 M |
| EPS (ttm) | -0.53 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2026 |
Market Cap Chart
Data Updated: 09/04/2026
GT Biopharma's yearly market capitalization.
GT Biopharma has seen its market value drop from $17.24 M to $10.38 M since 2014, representing a total decrease of 39.77% and an annual compound decline rate (CAGR) of 4.25%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 09/04/2026 | $10.38 M | 57.01% | 42351 |
| 12/31/2025 | $8.3 M | 22.06% | 39795 |
| 12/31/2024 | $6.8 M | -35.85% | 39698 |
| 12/29/2023 | $10.6 M | -63.19% | 36882 |
| 12/30/2022 | $28.8 M | -69.13% | 30500 |
| 12/31/2021 | $93.3 M | 181.02% | 23593 |
| 12/31/2020 | $33.2 M | 503.64% | 26590 |
| 12/31/2019 | $5.5 M | -83.13% | n/a |
| 12/31/2018 | $32.6 M | -84.14% | n/a |
| 12/29/2017 | $205.5 M | 7214.56% | n/a |
Company Profile
GT Biopharma was founded in 1965 in United States.
on the Nasdaq Stock Market.
With 1 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is GT Biopharma's (GTBP) current market cap?As of 09/04/2026, GT Biopharma (including the parent company, if applicable) has an estimated market capitalization of $10.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GT Biopharma (GTBP) rank globally by market cap?GT Biopharma global market capitalization ranking is approximately 42351 as of 09/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.